intro
types-of-study
other-lists-of-landmark-trials
going-deeper
recent-trials-see-twitter-feed
aki
aki-trials-in-other-chapters
association-of-aki-with-mortality-morbidity
contrast-associated-nephropathy
hepatorenal-syndrome
other-trials-in-aki
renal-anaemia
erythropoetin
iron
ckd-mbd
cinacalcet
phosphate-binders
HTN_CVS
hypertension
statins
cardiovascular-risk
renal-dennervation
renovascular-disease
ckd-proteinuria
egfr-calculation
association-of-egfr-and-proteinuria-with-hard-outcomes
competing-risk-of-death
rasi-progression-in-non-diabetic-disease
diabetic-kidney-disease
glycaemic-control
DKD_RASi
drasi_DKD
sglti
fluids-electrolytes-acid-base
hyponatraemia
hyperkalaemia
fluids
diuretic-therapy
metabolic-acidosis
acidosis-of-ckd
renal-tubular-acidosis
severe-metabolic-acidosis
glomerular-disease
proteinuria
igan
membranous
minimal-change
fsgs
Apol1
ahus
anca-vasculitis
induction
glucocorticoids-plasma-exchange
cyclophosphamide
rituximab
other-agents
maintenance
adjunctive-therapies
lupus-nephritis
induction-1
maintenance-1
newer-therapies
adpkd
blood-pressure-targets-and-rasi
vasopressin-antagonist-therapy
miscellaneous-conditions
myeloma
pregnancy
ain
tuberous-sclerosis
other
acute_RRT
dose
timing
chronic-dialysis
chronic-haemodialysis
modality
dose-1
initiation
peritoneal-dialysis
transplant
donors
donor-types
donor-aki
ischaemic-time
immunosuppression
desensitisation
cmv-disease
statin_Tx
rejection
historic-trials
seminal-basic-science
other-non-renal-specialties
critical-care
sepsis
cardio
haematology
